ProShares Ultra Nasdaq Biotechnology (BIB)
BIB Stock Price Chart
Explore ProShares Ultra Nasdaq Biotechnology interactive price chart. Choose custom timeframes to analyze BIB price movements and trends.
BIB Company Profile
Discover essential business fundamentals and corporate details for ProShares Ultra Nasdaq Biotechnology (BIB) to support your stock research and investment decisions.
Sector
Financial Services
Industry
Asset Management
IPO Date
7 Apr 2010
Employees
—
CEO
Description
ProShares Trust - ProShares Ultra Nasdaq Biotechnology is an exchange traded fund launched and managed by ProShare Advisors LLC. It invests in public equity markets of the United States. It invests through derivatives in stocks of companies operating across health care, pharmaceuticals, biotechnology, drugs manufacturer, diagnostic development and life sciences sectors. It uses derivatives such as swaps to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track 2x the daily performance of the Nasdaq Biotechnology Index, by using full replication technique. ProShares Trust - ProShares Ultra Nasdaq Biotechnology was formed on April 7, 2010 and is domiciled in the United States.
BIB Financial Timeline
Browse a chronological timeline of ProShares Ultra Nasdaq Biotechnology corporate events including earnings releases, dividend announcements, and stock splits.
BIB Stock Performance
Access detailed BIB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
